-
Pfizer Chief Medical Officer Joe Feczko had already defended Pfizer's arthritis medicines, Celebrex and Bextra.
FORBES: Pfizer's Tough Sell
-
Feczko emphasized that these drugs are different from Vioxx on a chemical level.
FORBES: Pfizer's Tough Sell
-
Pfizer Chief Medical Officer Joseph Feczko opposes the idea, saying the FDA already has plenty of incentive to yank drugs.
FORBES: Magazine Article